Home Cart Sign in  
Chemical Structure| 1016258-69-7 Chemical Structure| 1016258-69-7

Structure of 1016258-69-7

Chemical Structure| 1016258-69-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 1016258-69-7 ]

CAS No. :1016258-69-7
Formula : C14H26N2O4
M.W : 286.37
SMILES Code : O=C(N1CCC(C(OCC)=O)(CN)CC1)OC(C)(C)C
MDL No. :MFCD14525454
InChI Key :UHHUEAGCENEXAJ-UHFFFAOYSA-N
Pubchem ID :46839935

Safety of [ 1016258-69-7 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Application In Synthesis of [ 1016258-69-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1016258-69-7 ]

[ 1016258-69-7 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 1016258-66-4 ]
  • [ 1016258-69-7 ]
YieldReaction ConditionsOperation in experiment
83% at 25℃; for 24 h; 21C. 1-tert-Butyl 4-ethyl 4-(aminomethyl)piperidine-l,4-dicarboχylate; Platinum(IV) oxide (0.724 g, 3.19 mmol) and 1-tert-butyl 4-ethyl 4-cyanopiperidine-l,4- dicarboxylate (9g, 31.88 mmol) in acetic acid (100ml) were stirred under an atmosphere of hydrogen at 5 bar and 25 0C for 1 day. The crude product was filtered through celite and the filtrate purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 7M NH3/MeOH and pure fractions were evaporated to dryness to afford 1-tert-butyl 4-ethyl 4-(aminomethyl)piperidine-l,4- dicarboxylate (7.59 g, 83 percent) as a colourless oil.IH NMR (400.13 MHz, CDC13) δ 1.27 - 1.28 (3H, m), 1.30 - 1.37 (2H, m), 1.41 (2H, s), 1.45 (9H, s), 2.10 (2H, d), 2.78 (2H, s), 2.91 - 2.97 (2H, m), 3.89 (2H, s), 4.21 (2H, q).
83% at 25℃; for 24 h; Intermediate 8: 1-tert-butyl 4-ethyl 4-(aminomethyl)piperidine-l.,4-dicarboxylatePlatinum(IV) oxide (0.724 g, 3.19 mmol) and 1-tert-butyl 4-ethyl 4-cyanopiperidine-l,4- dicarboxylate (Intermediate 7) (9g, 31.9 mmol) in acetic acid (100ml) were stirred under an atmosphere of hydrogen at 5 bar and 25 0C for 1 day. The crude product was filtered through celite and the filtrate purified by ion exchange chromatography, using an SCX column. The desired product was eluted from the column using 7M NH3ZMeOH and pure fractions were evaporated to dryness to afford 1-tert-butyl 4-ethyl 4- (aminomethyl)piperidine-l,4-dicarboxylate (7.59 g, 83 percent) as a colourless oil.IH NMR (400.13 MHz, CDC13) δ 1.27 - 1.28 (3H, m), 1.30 - 1.37 (2H, m), 1.41 (2H, s), 1.45 (9H, s), 2.10 (2H, d), 2.78 (2H, s), 2.91 - 2.97 (2H, m), 3.89 (2H, s), 4.21 (2H, q).
References: [1] Patent: WO2008/75110, 2008, A1, . Location in patent: Page/Page column 127.
[2] Patent: WO2009/47563, 2009, A1, . Location in patent: Page/Page column 88.
[3] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 19, p. 5910 - 5915.
  • 2
  • [ 4395-98-6 ]
  • [ 1016258-69-7 ]
References: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 19, p. 5910 - 5915.
  • 3
  • [ 24424-99-5 ]
  • [ 1016258-69-7 ]
References: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 19, p. 5910 - 5915.
  • 4
  • [ 91419-52-2 ]
  • [ 1016258-69-7 ]
References: [1] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 19, p. 5910 - 5915.
 

Historical Records

Categories